Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
M
432980
vs
K
KOSPI 200
Over the past 12 months, MFC Co Ltd has underperformed KOSPI 200, delivering a return of -23% compared to KOSPI 200's +50% growth.
Stocks Performance
432980 vs KOSPI 200
Performance Gap
432980 vs KOSPI 200
Performance By Year
432980 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
MFC Co Ltd
Glance View
MFC Co., Ltd. is a pharmaceutical company that engages in pharmaceutical research and development, API''s, pharmaceutical intermediaries, Pd catalyst, and custom manufacturing services. The company is headquartered in Hwaseong, Gyeonggi-Do and currently employs 65 full-time employees. The company went IPO on 2024-12-26. The firm operates its business through two segments. The Active Pharmaceutical Ingredient (API) and Key Material segment is mainly engaged in the development and production of APIs for generic drugs and related key intermediate materials. The Improved New Drug API segment is mainly engaged in developing and producing APIs for improved new drugs, leveraging the technological expertise accumulated through the aforementioned API and key material segments.